Thursday, February 3, 2022
12:00pm - 1:00pm
Zoom Attendance Only
Dr. Bill Calhoun
Division of Pulmonary, Allergy & Clinical Immunology
Vice Chair of Research
“A Comprehensive Review of Biologics in Asthma”
Objectives: At this conclusion of this presentation, participants should be able to:
- Describe at least 4 inflammatory pathways that can be targeted by biologic therapy for asthma
- Compare clinical and molecular phenotypes of asthma patients who respond to particular biologic therapies
- List relevant outcome measures that are benefitted by biologic therapy for asthma
Target Audience and Needs: Internal Medicine faculty, staff, registered nurses, residents, fellows, students, and internists specializing in Allergy & Immunology,
Cardiology, Endocrinology, Gastroenterology, General Medicine, Geriatrics, Hematology & Oncology, Infectious Diseases, Nephrology, Palliative Care, Pulmonary Critical Care & Sleep Medicine, and Rheumatology need to be regularly updated
with new research and guidelines regarding the evaluation and management of medical disorders and implement them in clinical practice to enhance the quality of patient care and improve patient outcomes.
Educational Methods: Educational methods will include lectures, case presentations, literature review, and panel discussion.
Activity Evaluation: Participants may be asked to complete a session evaluation.
Accreditation/Credit Designation: The University of Texas Medical Branch is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
The University of Texas Medical Branch designates this live activity for a maximum of _1_ AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Everyone is welcome.